Clinical Trials Logo

Venlafaxine clinical trials

View clinical trials related to Venlafaxine.

Filter by:
  • Recruiting  
  • Page 1

NCT ID: NCT04973930 Recruiting - Breast Cancer Clinical Trials

Feasibility Trial of Tele-IPT and Tele-Pharmacotherapy for Patients With Depression and Non-Metastatic Breast Cancer

IPT
Start date: March 1, 2022
Phase: Phase 3
Study type: Interventional

Cancer and depression commonly occur together, and each worsens the other. We conducted a large psychotherapy study treating depression in breast cancer patients, showing that psychotherapy lowers symptoms. Surprisingly, no studies have compared depression-focused psychotherapy to antidepressant medication for patients with breast cancer and depression. We applied to the National Cancer Institute for a large, cross-national grant. Reviewers asked us to first demonstrate that patients would accept either psychotherapy or medication as treatment. Thanks to funding from the Columbia Herbert Irving Cancer Center, we will test this study approach. We will randomly assign 20 patients with both non-metastatic breast cancer and major depression to 12 weeks of tele-therapy (by Zoom) with either interpersonal psychotherapy or a serotonin reuptake inhibitor. We expect patients in both treatments to report improvement in depression symptoms. We will also measure C-reactive protein, a blood test of inflammation elevated in both cancer and depression, which may predict medication response.

NCT ID: NCT01204086 Recruiting - Clinical trials for Major Depressive Disorder

Pharmacogenomics Studies of Antidepressants

Start date: March 2007
Phase: Phase 4
Study type: Interventional

The purpose of this study is to establish the clinical effectiveness of antidepressants by pharmacogenomic approach, and to determine the levels of inflammatory factors between the baseline and the end point of the study in Taiwanese major depressive disorder (MDD) patients.